Focused Ultrasound: Crossing Barriers to Treat Alzheimer‘s Disease

• Carter MD , SimmsGA, WeaverDF. The development of new therapeutics for Alzheimer‘s disease. Clin. Pharmacol. Ther.88, 475–486 (2010).
   PubMed Web of Science ®Google Scholar
• Massoud F , GauthierS. Update on the pharmacological treatment of Alzheimer‘s disease. Curr. Neuropharmacol.8, 69–80 (2010).
   PubMed Web of Science ®Google Scholar
• Pardridge WM . Alzheimer‘s disease drug development and the problem of the blood–brain barrier. Alzheimers Dement.5, 427–432 (2009).
   PubMed Web of Science ®Google Scholar
• Hynynen K , McDannoldN, VykhodtsevaN, JoelszFA. Noninvasive MR imaging-guided focal opening of the blood–brain barrier in rabbits. Radiology220, 640–646 (2001).
   PubMed Web of Science ®Google Scholar
• Vykhodtseva N , McDannoldN, HynynenK. Progress and problems for the application of focused ultrasound for blood–brain barrier disruption. Ultrasonics48, 279–296 (2008).
   PubMed Web of Science ®Google Scholar
• Hynynen K , McDannoldN. MRI guided and monitored focused ultrasound thermal ablation methods: a review of progress. Int. J. Hyperthermia20, 725–737 (2004).
   PubMed Web of Science ®Google Scholar
• Hernot S , KlibanovAL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv. Drug Deliv. Rev.60, 1153–1166 (2008).
   PubMed Web of Science ®Google Scholar
• Hynynen K . Ultrasound for drug and gene delivery to the brain. Adv. Drug Deliv. Rev.60, 1209–1217 (2008).
   PubMed Web of Science ®Google Scholar
• Lynn JG , ZwemerRL, ChickAJ, MillerAE. A new method for the generation and use of focused ultrasound in experimental biology. J. Gen. Physiol.26, 179–193 (1942).
   PubMedGoogle Scholar
• Fry WJ , MosbergWH, BarnardJW, FryFJ. Production of focal destructive lesions in the central nervous system with ultrasound. J. Neurosurg.11, 471–478 (1954).
   PubMed Web of Science ®Google Scholar
• Hynynen K , ClementG. Clinical applications of focused ultrasound – the brain. Int. J Hypotehrmia23, 193–202 (2007).
   PubMed Web of Science ®Google Scholar
• Hynynen K , DarkazanliA, UngerE, SchenckJF. MRI-guided noninvasive ultrasound surgery. Med. Phys.20, 107–115 (1993).
   PubMed Web of Science ®Google Scholar
• Cline HE . Hynynen K, Hardy CJ, Watkins RD, Schenck FJ, Jolesz FA. MR temperature mapping of focused ultrasound surgery. Magn. Reson. Med.30, 98–106 (1994).
   Web of Science ®Google Scholar
• McDannold N , ClementGT, BlackP, JoleszF, HynynenK. Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurg.66, 323–332 (2010).
   PubMed Web of Science ®Google Scholar
• Martin E , JeanmonodD, MorelA, ZadicarioE, WernerB. High-intensity focused ultrasound for noninvasive functional neurosurgery. Ann. Neurol.66, 858–861 (2009).
   PubMed Web of Science ®Google Scholar
• Vykhodtseva N . Effects of high intensity pulsed ultrasound on brain tissues. Proceedings of: The 5th International Symposium on Ultrasound in Biological Medicine. Puschino, Russia 7–11 September 1981.
   Google Scholar
• McDannold N , VykhodtsevaN, JoleszFA. MRI investigation of the threshold for thermally induced blood–brain barrier disruption and brain-tissue damage in the rabbit brain. Magn. Reson. Med.51, 913–923 (2004).
   PubMed Web of Science ®Google Scholar
• Mesiwala AH , FarrellL, WenzelHJet al. High-intensity focused ultrasound selectively disrupts the blood–brain barrier in vivo. Ultrasound Med. Biol. 28, 389–400 (2004).
   Web of Science ®Google Scholar
• McDannold N , VykhodtsevaN, HynynenK. Targeted disruption of the blood–brain barrier with focused ultrasound: associated with cavitation activity. Phys. Med. Biol.51, 793–807 (2006).
   PubMed Web of Science ®Google Scholar
• Tung YS , VlachosF, ChoiJJ, DeffieuxT, SelertK, JonofagouEE. In vivo transcranial cavitation threshold detection during ultrasound-induced blood–brain barrier opening in mice. Phys. Med. Biol.55, 6141–6155 (2010).
   PubMed Web of Science ®Google Scholar
• Sheikov N , McDannoldN, SharmaS, HynynenK. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med. Biol.34, 1093–1104 (2008).
   PubMed Web of Science ®Google Scholar
• Sheikov N , McDannoldN, VykhodtsevaN, JoleszF, HynynenK. Cellular mechanisms of the blood–brain barrier opening induced by ultrasound in the presence of microbubbles. Ultrasound Med. Biol.30, 979–989 (2004).
   PubMed Web of Science ®Google Scholar
• McDannold N , VykhodtsevaN, RaymondS, JoelszFA, HynynenK. MRI-guided targeted blood–brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med. Biol.31, 1527–1537 (2005).
   PubMed Web of Science ®Google Scholar
• Rapoport SI . Advances in osmotic opening of the blood–brain barrier to enhance CNS chemotherapy. Expert Opin. Investig. Drugs10, 1809–1818 (2001).
   PubMed Web of Science ®Google Scholar
• Zunkeler B , CarsonRE, OlsonJ, BlasbergRG, DeVroomH, LutzRJ. Quantification and pharmacokinetics of blood–brain barrier disruption in humans. J. Neurosurg.85, 1056–1065 (1996).
   PubMed Web of Science ®Google Scholar
• Matsukado K , SugitaM, BlackKL. Intracarotid lose dose bradykinin infusion selectively increases tumor permeability through activation of B2 receptors in malignant gliomas. Brain Res.792, 10–15 (1998).
   PubMed Web of Science ®Google Scholar
• Hanig JP , MorrisonJM Jr, Krop S. Ethanol enhancement of blood brain barrier permeability to catecholamines in chicks. Eur. J. Pharmacol.18, 79–82 (1972).
   PubMed Web of Science ®Google Scholar
• Broadwell RD , SalcmanM, KaplanRS. Morphologic effect of dimethyl sulfoxide on the blood–brain barrier. Science217, 164–166 (1982).
   PubMed Web of Science ®Google Scholar
• Hynynen K , McDannoldN, SheikovNA, JoleszFA, VykhodtsevaN. Local and reversible blood–brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonciations. NeuroImage24, 12–20 (2005).
   PubMed Web of Science ®Google Scholar
• Hynynen K , McDannoldN, VykhodtsevaNet al. Focal disruption of the blood–brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg. 105, 445–454 (2006).
   PubMed Web of Science ®Google Scholar
• Panza F , FrisardiV, ImbimboBPet al. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer‘s disease. Immunotherapy 2, 767–782 (2010).
   PubMed Web of Science ®Google Scholar
• Hynynen K . MRI-guided focused ultrasound treatments. Ultrasonic50, 221–229 (2010).
   PubMed Web of Science ®Google Scholar
• Bard F , CannonC, BarbourRet al. Peripherally administered antibodies against amyloid β-peptideenter the central nervous system and reduce pathology in a mouse model of Alzheimer‘s disease. Nat. Med. 6, 916–919 (2000).
   PubMed Web of Science ®Google Scholar
• Thakker DR , WeatherspoonMR, HarrisonJ, KeeneTE, LaneDS. Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice. Proc. Natl Acad. Sci. USA106, 4501–4506 (2009).
   PubMed Web of Science ®Google Scholar
• Wilcock DM , DiCarloG, HendersonD, JacksonJ, ClarkeK. Intracranially administered anti-Aβ antibodies reduce β-amyloid deposition by mechanisms both independent of and associated with microglial activation. J. Neurosci.23, 3745–3751 (2003).
   PubMed Web of Science ®Google Scholar
• Kinoshita M , McDannoldN, JoleszFA, HynynenK. Targeted delivery of antibodies through the blood–brain barrier by MRI-guided focused ultrasound. Biochem. Biophys. Res. Commun.340, 1085–1090 (2006).
   PubMed Web of Science ®Google Scholar
• Kinoshita M , McDannoldN, JoleszFA, HynynenK. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood–brain barrier disruption. Proc. Natl Acad. Sci. USA103, 11719–11723 (2006).
   PubMed Web of Science ®Google Scholar
• Weller RO , PrestonSD, SubashM, CarareRO. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer‘s disease. Alzheimers Res. Ther.1, 6–19 (2009).
   PubMed Web of Science ®Google Scholar
• Choi JJ , WangS, BrownTR, SmallSA, DuffKE, KonofagouEE. Noninvasive and transient blood–brain barrier opening in the hippocampus of Alzheimer‘s double transgenic mice using focused ultrasound. Ultrasonic Imaging30, 189–200 (2008).
   PubMed Web of Science ®Google Scholar
• Raymond SB , TreatLH, DeweyJD, McDannoldNJ, HynynenK, BacskaiBJ. Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer‘s disease mouse models. PLoS One3, 1–7 (2008).
   Google Scholar
• Jordão JF , Ayala-GrossoCA, MarkhamKet al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-β plaque load in the TgCRND8 mouse model of Alzheimer‘s disease. PLoS One 5, 1–8 (2010).
   Web of Science ®Google Scholar
• Holtzman DM . Alzheimer‘s disease: moving towards a vaccine. Nature454, 418–420 (2008).
   PubMed Web of Science ®Google Scholar
• Gura T . Hope in Alzheimer‘s fight emerges from unexpected places. Nat. Med.14, 894 (2008).
   PubMed Web of Science ®Google Scholar
• Bowman ND , KayeMD, MooreBS, WaichunasBA, CarlsonNE, QuinnJF. Blood–brain barrier impairment in Alzheimer‘s disease: stability and functional significance. Neurology68, 1809–1814 (2007).
   PubMed Web of Science ®Google Scholar
• Lo EH , SinghalAB, TorchilinVP. Drug delivery to the damaged brain. Brain Res. Rev.38, 140–148 (2001).
   PubMed Web of Science ®Google Scholar
• Tyler WJ , TufailY, FinsterwaldM, TauchmannML, OlsonEJ, MajesticC. Remote excitation of neuronal circuits using low-intensity, low frequency ultrasound. PLoS One3, 1–11 (2008).
   Google Scholar
• Tufail Y , MatyushovA, BaldwinNet al. Transcranial pulsed ultrasound stimulates intact brain circuits. Neuron. 66, 681–694 (2010).
   PubMed Web of Science ®Google Scholar

Website

• Alzheimer‘s Association. 2010 Alzheimer‘s Disease Facts and Figures. www.alz.org/documents_custom/report_alzfactsfigures2010.pdf
   Google Scholar